A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study
Clinical trial NCT03382431 · COMPLETED
Trial details
- NCT number
- NCT03382431
- Sponsor
- Pulmocide Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-14
- Primary completion
- 2018-05-09
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.